Fetal Alcohol Spectrum Disorders (FASD) is an umbrella term used to describe the range of disability that can result from prenatal alcohol exposure. FASD is an important public health and social issue associated with a large burden on society through the healthcare system, mental health and substance abuse system, foster care, criminal justice system, and long-term disability care services. This project included an environmental scan of the policies and programs of selected states and technical expert panel comprised of national experts on FASD to better understand how states are addressing this complex problem. ASPE is publishing two briefs based on the findings from this project. The first brief synthesizes effective state and local level strategies for prevention, identification and intervention. The second brief reviews the role of health and human service providers in preventing FASD.
These briefs were prepared under contract #HHSP233201600021I between the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Behavioral Health, Disability, and Aging Policy and RTI International. For additional information about this subject, you can visit the BHDAP home page at https://aspe.hhs.gov/about/offices/bhdap or contact the ASPE Project Officers at HHS/ASPE/BHDAP, Room 424E, H.H. Humphrey Building, 200 Independence Avenue, S.W., Washington, D.C. 20201; Kristina.West@hhs.gov, Mir.Ali@hhs.gov.
- State Responses to FASD: Effective Strategies and Ongoing Challenges Research Brief
- The Role of Health and Human Service Providers in Preventing Fetal Alcohol Spectrum Disorders Research Brief
- Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use
- Alcohol and Other Drug Treatment for Parents and Welfare Recipients: Outcomes, Costs and Benefits
- Risk and Reality: The Implications of Prenatal Exposure to Alcohol and Other Drugs
- Status Report on Protecting Our Infants Act Implementation Plan
- State Policy Levers for Expanding Family-Centered Medication-Assisted Treatment